Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 80 of the 80 references it cites were found in a registry or an index.

Diabetic Kidney Disease: Challenges, Progress, and Possibilities

Open access
Alicic, Radica Z., Rooney, Michele T., Tuttle, Katherine R. · 2017 · Clinical Journal of the American Society of Nephrology

Abstract

Diabetic kidney disease develops in approximately 40% of patients who are diabetic and is the leading cause of CKD worldwide. Although ESRD may be the most recognizable consequence of diabetic kidney disease, the majority of patients actually die from cardiovascular diseases and infections before needing kidney replacement therapy. The natural history of diabetic kidney disease includes glomerular hyperfiltration, progressive albuminuria, declining GFR, and ultimately, ESRD. Metabolic changes associated with diabetes lead to glomerular hypertrophy, glomerulosclerosis, and tubulointerstitial inflammation and fibrosis. Despite current therapies, there is large residual risk of diabetic kidney disease onset and progression. Therefore, widespread innovation is urgently needed to improve health outcomes for patients with diabetic kidney disease. Achieving this goal will require characterization of new biomarkers, designing clinical trials that evaluate clinically pertinent end points, and development of therapeutic agents targeting kidney-specific disease mechanisms ( e.g. , glomerular hyperfiltration, inflammation, and fibrosis). Additionally, greater attention to dissemination and implementation of best practices is needed in both clinical and community settings.Introduction

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2215/cjn.11491116

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Research works printed but not linked: 2

  1. 2016, Standards of medical care in diabetes-2016: Summary of revisions, Diabetes Care, 39, S4
  2. Bakris, 2015, Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group. Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial, JAMA, 314, 884, 10.1001/jama.2015.10081 · DOI · Paper page

Cited by

See all 2,898

Metadata

Authors
Alicic, R. Z., Rooney, M. T., & Tuttle, K. R.
Affiliations
  • University of Washington (US)
  • Providence Health Care, Spokane, Washington;
Corresponding author
  • Alicic, Radica Z.
  • Rooney, Michele T.
  • Tuttle, Katherine R.
Venue
Clinical Journal of the American Society of Nephrology
Published
2017-05-18
Volume
12
Issue
12
Pages
2032-2045
ISSN
  • 1555-9041 (ISSN-L)
  • 1555-905X
OpenAlex
W2615714795
Cited by
2,898
References
80
Citations by year
2026: 430 · 2025: 412 · 2024: 442 · 2023: 458 · 2022: 424 · 2021: 337 · 2020: 246 · 2019: 107 · 2018: 32 · 2017: 8
FWCI
96.16
Type
journal article
Language
en
Open access
Locations
  • Clinical Journal of the American Society of Nephrology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
diabetic nephropathy, chronic kidney disease, end-stage renal disease, glomerular hyperfiltration, albuminuria, glomerulosclerosis, tubulointerstitial fibrosis, cardiovascular mortality, biomarkers, therapeutic target, disease progression, best practice implementation
MeSH terms
Diabetic Nephropathies, Glomerular Filtration Rate, Humans, Hyperglycemia, Hypertension, Hypoglycemic Agents, Kidney Failure, Chronic, Risk Factors, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetic Kidney Disease: Challenges, Progress, and Possibilities. https://app.cochat.ai/papers/10.2215/cjn.11491116
The paper
Alicic, R. Z., Rooney, M. T., & Tuttle, K. R. (2017). Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.11491116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.